Literature DB >> 1657016

Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication.

N R Swerdlow1, R Hauger, M Irwin, G F Koob, K T Britton, L Pulvirenti.   

Abstract

In humans who chronically abuse amphetamine (AMPH), sudden abstinence often precipitates an organic mood disorder that mimics many symptoms of major depression. We report that AMPH exposure and withdrawal in rats modifies hypothalamic-pituitary-adrenal axis endocrine responses, peripheral immune functions, and regional brain catecholamine levels. Compared to vehicle-treated animals, rats treated with AMPH for 10 days exhibit significantly decreased physostigmine-induced release of adrenocorticotropin hormone (ACTH). During AMPH withdrawal, these animals show a loss of the normal correlation between levels of plasma ACTH and corticosterone. Chronic AMPH treatment in rats causes a significant increase in natural killer cell activity. Brain dopamine levels in these animals are decreased in the caudate nucleus but are increased in the nucleus accumbens. AMPH withdrawal in rats may be a useful model for studying the physiologic and neural substrates of human AMPH withdrawal states.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657016

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  8 in total

Review 1.  Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Authors:  Lisa R Norman; Michael Basso; Anil Kumar; Robert Malow
Journal:  Curr Drug Abuse Rev       Date:  2009-05

2.  An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.

Authors:  D S Segal; R Kuczenski
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

3.  An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.

Authors:  R Kuczenski; D S Segal
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

Review 4.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015

5.  Inhibition by amphetamine of testosterone secretion through a mechanism involving an increase of cyclic AMP production in rat testes.

Authors:  S C Tsai; Y C Chiao; C C Lu; M L Doong; Y H Chen; H C Shih; C Liaw; S W Wang; P S Wang
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 6.  Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2007-06-29       Impact factor: 3.996

7.  Association of leukocytosis with amphetamine and cocaine use.

Authors:  John R Richards; Valeria F Farias; Chris S Clingan
Journal:  ScientificWorldJournal       Date:  2014-01-22

8.  Prolonged Peripheral Immunosuppressive Responses as Consequences of Random Amphetamine Treatment, Amphetamine Withdrawal and Subsequent Amphetamine Challenges in Rats.

Authors:  Wojciech Glac; Joanna Dunacka; Beata Grembecka; Grzegorz Świątek; Irena Majkutewicz; Danuta Wrona
Journal:  J Neuroimmune Pharmacol       Date:  2021-02-13       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.